Publications by authors named "Karl Vergote"

Claim this Profile
S
S. mansoni -derived omega-1 prevents OVA-specific allergic airway inflammation via hampering of cDC2 migration.
Thiago A Patente, Thomas A Gasan, Maaike Scheenstra, Arifa Ozir-Fazalalikhan, Katja Obieglo, Karl Vergote

PLoS Pathog· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canonical IRE1 function needed to sustain vigorous natural killer cell proliferation during viral infection.
Jessica Vetters, Mary van Helden, Clint De Nolf, Sofie Rennen, Eva Cloots, Karl Vergote

iScience· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The STE20 kinase TAOK3 controls the development of house dust mite-induced asthma in mice.
Bastiaan Maes, Ursula Smole, Matthias Vanderkerken, Kim Deswarte, Justine Van Moorleghem, Karl Vergote

J Allergy Clin Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ORMDL3 asthma susceptibility gene regulates systemic ceramide levels without altering key asthma features in mice.
Nincy Debeuf, Assem Zhakupova, Regula Steiner, Sofie Van Gassen, Kim Deswarte, Karl Vergote

J Allergy Clin Immunol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ubiquitin-editing enzyme A20 controls NK cell homeostasis through regulation of mTOR activity and TNF.
Jessica Vetters, Mary J van Helden, Sigrid Wahlen, Simon J Tavernier, Arne Martens, Karl Vergote

J Exp Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-33trap is a novel IL-33-neutralizing biologic that inhibits allergic airway inflammation.
Aurora Holgado, Harald Braun, Elien Van Nuffel, Sammy Detry, Martijn J Schuijs, Karl Vergote

J Allergy Clin Immunol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bispecific antibody strategy to target multiple type 2 cytokines in asthma.
Marie Godar, Kim Deswarte, Karl Vergote, Michael Saunders, Hans de Haard

J Allergy Clin Immunol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulated IRE1-dependent mRNA decay sets the threshold for dendritic cell survival.
Simon J Tavernier, Fabiola Osorio, Lana Vandersarren, Jessica Vetters, Nele Vanlangenakker, Karl Vergote

Nat Cell Biol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitional B cells commit to marginal zone B cell fate by Taok3-mediated surface expression of ADAM10.
Hamida Hammad, Matthias Vanderkerken, Philippe Pouliot, Kim Deswarte, Wendy Toussaint, Karl Vergote

Nat Immunol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesterol-sensing liver X receptors stimulate Th2-driven allergic eosinophilic asthma in mice.
Muriel Smet, Lien Van Hoecke, Ans De Beuckelaer, Seppe Vander Beken, Thomas Naessens, Karl Vergote

Immun Inflamm Dis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively.
Dorine Sichien, Charlotte L Scott, Liesbet Martens, Matthias Vanderkerken, Sofie Van Gassen, Karl Vergote

Immunity· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells.
Martijn J Schuijs, Monique A Willart, Karl Vergote, Delphine Gras, Kim Deswarte

Science· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung tumours reprogram pulmonary dendritic cell immunogenicity at the microRNA level.
Lotte Pyfferoen, Pieter Mestdagh, Karl Vergote, Nancy De Cabooter, Jo Vandesompele

Int J Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis